| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/23/2001 | CA2398825A1 Gtpase activating proteins |
| 08/23/2001 | CA2398628A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, andantagonists thereof |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2398482A1 Cell fusion assays using fluorescence resonance energy transfer |
| 08/23/2001 | CA2396793A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | CA2395187A1 Molecular imprinting compositions and methods for binding and analyzing macromolecules |
| 08/22/2001 | EP1126035A1 Method for detecting gene affected by endocrine disruptor |
| 08/22/2001 | EP1126034A2 Coding sequences of the human BRCA1 gene |
| 08/22/2001 | EP1126031A1 Non human helper dependent viral vector |
| 08/22/2001 | EP1126030A1 Thioredoxin reductase ii |
| 08/22/2001 | EP1126029A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126027A1 Cell death inhibition by the caspase-12 activation inhibitor MAGE-3 |
| 08/22/2001 | EP1126025A2 Oligonucleotide modulation of protein kinase C |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1125943A1 Process for the purification of biological macromolecules and chromatographic column to carry out the process |
| 08/22/2001 | EP1125905A1 Segment synthesis |
| 08/22/2001 | EP1125128A1 Method for gold deposition |
| 08/22/2001 | EP1125107A1 Tests for the rapid evaluation of ischemic states and kits |
| 08/22/2001 | EP1124993A2 Novel primers and probes for detecting hiv |
| 08/22/2001 | EP1124992A1 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| 08/22/2001 | EP1124991A1 Phytomics: a genomic-based approach to herbal compositions |
| 08/22/2001 | EP1124990A1 Complexity management and analysis of genomic dna |
| 08/22/2001 | EP1124989A1 Method for determining cancer by determining expression of mage-10 |
| 08/22/2001 | EP1124988A1 Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi |
| 08/22/2001 | EP1124987A2 Methods for screening protease variants for use in detergent compositions |
| 08/22/2001 | EP1124984A1 Host cells expressing recombinant human erythropoietin |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124978A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 08/22/2001 | EP1124977A1 Modified adenoviral fibre and uses thereof |
| 08/22/2001 | EP1124976A1 Improved aav vector production |
| 08/22/2001 | EP1124974A2 Hypersensitive response elicitor-induced stress resistance |
| 08/22/2001 | EP1124973A1 Antibody-mediated down-regulation of plant proteins |
| 08/22/2001 | EP1124972A1 VECTOR FOR THE TRANSFORMATION OF $i(PHAFFIA RHODOZYMA) AND PROCESS OF TRANSFORMATION THEREBY |
| 08/22/2001 | EP1124971A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 08/22/2001 | EP1124970A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography |
| 08/22/2001 | EP1124969A2 Recombinant oleandolide polyketide synthase |
| 08/22/2001 | EP1124968A2 Library of novel "unnatural" natural products |
| 08/22/2001 | EP1124967A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124963A2 Disease resistance factors |
| 08/22/2001 | EP1124962A1 Maize kin17 orthologues and uses thereof |
| 08/22/2001 | EP1124961A2 Thrombopoietic compounds |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124957A1 Pholasin |
| 08/22/2001 | EP1124956A2 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
| 08/22/2001 | EP1124955A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60) |
| 08/22/2001 | EP1124954A2 Scorpion toxins |
| 08/22/2001 | EP1124953A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/22/2001 | EP1124952A2 Therapeutic antiangiogenic endostatin compositions |
| 08/22/2001 | EP1124951A2 Human sorting nexins |
| 08/22/2001 | EP1124950A2 p53 ANTISENSE AGENT AND METHOD |
| 08/22/2001 | EP1124949A1 Constructing and screening a dna library of interest in filamentous fungal cells |
| 08/22/2001 | EP1124948A1 Method for generating a gene library |
| 08/22/2001 | EP1124947A2 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
| 08/22/2001 | EP1124946A1 Glycosylated proteins having reduced allergenicity |
| 08/22/2001 | EP1124944A2 Mutant luciferase having increased thermostability |
| 08/22/2001 | EP1124943A1 Nucleic acids encoding taxus geranylgeranyl diphosphate synthase, and methods of use |
| 08/22/2001 | EP1124941A1 Process for recovering heterologous polypeptides from bacterial cells |
| 08/22/2001 | EP1124856A1 Conformation-specific anti-von willebrand factor antibodies |
| 08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
| 08/22/2001 | EP1124854A2 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer |
| 08/22/2001 | EP1124853A1 Anti-petasin antibodies, methods for the production thereof and their use |
| 08/22/2001 | EP1124852A1 Lysine-rich statherin protein |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124844A1 G protein-coupled receptor resembling the thrombin receptor |
| 08/22/2001 | EP1124843A1 Low allergenic protein variants |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124838A2 Nucleic acid labeling compounds |
| 08/22/2001 | EP1124835A1 Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection |
| 08/22/2001 | EP1124799A1 Method for preparing methionine |
| 08/22/2001 | EP1124723A1 Fuel nozzle dispenser using ultrasonic metering |
| 08/22/2001 | EP1124637A2 Multi-well microfiltration apparatus |
| 08/22/2001 | EP1124583A1 Adeno-associated vectors for expression of factor viii by target cells |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
| 08/22/2001 | EP1124568A1 Polyspecific binding molecules and uses thereof |
| 08/22/2001 | EP1124417A2 Compositions comprising plant cell growth regulating compounds and methods of use thereof |
| 08/22/2001 | EP1124411A1 New plants formed by microparticle bombardment with uncharacterised dna |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP1085811A4 Broad specificity dna damage endonuclease |
| 08/22/2001 | EP0931165A4 Measurement of gene expression profiles in toxicity determination |
| 08/22/2001 | EP0917583B1 Maize promoter sequence for leaf- and stalk-preferred gene expression |
| 08/22/2001 | EP0904354A4 NOVEL PLANT STEROID 5alpha REDUCTASE, DET2 |
| 08/22/2001 | EP0809516B1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/2001 | EP0764204B1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 08/22/2001 | EP0725794B1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 08/22/2001 | EP0673255B1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 08/22/2001 | EP0616645B1 Prohormone convertase transformed cells |
| 08/22/2001 | EP0550645B1 Surface expression libraries of heteromeric receptors |
| 08/22/2001 | EP0309565B2 Subtilisin analogs |
| 08/22/2001 | CN1309766A Instrument for monitoring polymerase chain reaction of DNA |
| 08/22/2001 | CN1309722A Quantitative methods, systems and apparatuses for gene expression analysis |